Kobayashi M, Imai K, Nakai K, Kumasaka F, Suzuki T, Ito Y, Yamanaka H, Sugihara S
Hinyokika Kiyo. 1986 Mar;32(3):375-83.
Nineteen patients with renal cell carcinoma who had undergone radical nephrectomy have been treated with a combination of chemotherapy and partly hormonal therapy using ACNU, vinblastine and chloromadinone acetate. The efficacy of the combination therapy in advanced renal cell carcinoma was studied and only one out of nineteen cases having lung and pleural metastasis shows no change lasting from one to eighteen months. The prophylactic efficacy was studied in eighteen patients with stage I to IVA renal cell carcinoma (contained one patient with stage IVA renal cell carcinoma who had undergone radical nephrectomy and coecum resection for coecum invasion). Tumor recurrence occurred in 5 cases, that is 5 cases within 1 year and 1 case within 2 years. The combination of chemotherapy using ACNU & vinblastine must be used carefully for severe side effects.
19例接受根治性肾切除术的肾细胞癌患者接受了化疗与部分激素治疗的联合方案,使用了阿糖胞苷、长春花碱和醋酸氯地孕酮。研究了该联合疗法对晚期肾细胞癌的疗效,19例中有1例发生肺和胸膜转移,病情持续1至18个月无变化。对18例I至IVA期肾细胞癌患者(其中1例IVA期肾细胞癌患者因盲肠侵犯接受了根治性肾切除术和盲肠切除术)进行了预防疗效研究。5例出现肿瘤复发,即1年内复发5例,2年内复发1例。由于严重的副作用,必须谨慎使用阿糖胞苷和长春花碱联合化疗。